Emerson introduces multiparameter intelligent analyzer with three measurement inputs
September 24, 2008
New instrument offers expanded analytical inputs and multiple analog outputs to serve OEMs, systems integrators and analytical end users IRVINE, Calif., September 24, 2008 – To meet the need for multiple liquid measurements and lower costs per measurement loop required by industrial OEMs and other analytical customers, Emerson Process Management has announced the Rosemount Analytical [...]
New instrument can quickly examine multiple proteins in a single cancer sample
September 23, 2008
PHILADELPHIA -- Researchers have demonstrated a new instrument that makes it possible to detect and quantify multiple different clinically important proteins in a single tumor sample using conventional staining. Currently, pathologists usually need a separate tissue slice for each protein they want to examine, making it impossible to see how molecules interact within individual cells. [...]
LabVantage Awarded GSA Schedule Contract To Simplify LIMS Procurement by Federal Agencies
September 23, 2008
Bridgewater, NJ. September 23, 2008. LabVantage announced today that it has been awarded a five-year Information Technology (IT) Schedule 70 Contract with the United States (U.S.) General Services Administration (GSA) to sell its SAPPHIRE Laboratory Information Management Suite (LIMS) and related services to eligible U.S. federal agencies and their subordinate entities. The GSA Schedule leverages [...]
September 23, 2008
Acquisition of Center for Molecular Medicine Positions Sequenom for Commercial Launch of SEQureDx(TM) Test in First Half 2009 Daniel H. Farkas, Ph.D. to Join Sequenom Management Team SAN DIEGO--Sequenom (NASDAQ:SQNM - News) today announced that it entered into an agreement to acquire the Center for Molecular Medicine (CMM), a Clinical Laboratory Improvement Act (CLIA) certified [...]
U.S. Genomics Inc. Receives $4.5 Million Investment from BD
September 23, 2008
WOBURN, Mass., Sept. 23 -- U.S. Genomics today announced it has received a $4.5 million equity investment from BD (Becton, Dickinson and Company) and that the companies have entered into a strategic collaboration for development of a novel infectious disease diagnostic platform. The collaboration will focus on application of U.S. Genomics' DirectLinear Analysis(TM) technology (DLA) [...]
ForteBio, Inc. Closes $25 Million In Series C Financing
September 23, 2008
MENLO PARK, Calif., Sept. 23 -- ForteBio(R), Inc., a leading supplier of label-free technology that accelerates the development of life science and pharmaceutical products, today announced the closing of $25 million in Series C financing, led by OrbiMed Advisors, a top global healthcare investment firm. MPM Capital also participated as a new investor in this [...]
250th Peer-Reviewed Publication Documents the Success of 454 Sequencing
September 23, 2008
BRANFORD, Conn.--454 Life Sciences, a Roche company, today announced the publication of the 250th peer-reviewed study using the Genome Sequencer System. Researchers are taking advantage of the high accuracy and long reads that the Genome Sequencer FLX System provides to quickly generate high quality, biologically relevant results. These results are yielding breakthrough publications, giving 454 [...]
Sequenom Announces Additional, Positive Results for Down Syndrome Test at Analyst Briefing
September 23, 2008
Sequenom, Inc. (NASDAQ:SQNM), a leading provider of genetic-analysis and molecular diagnostic solutions, announced additional, positive results from screening studies using the Company's noninvasive circulating cell-free fetal (ccff) nucleic acid SEQureDx(TM) Technology, which enables the detection of fetal aneuploidy, including Down syndrome from maternal blood, at its Analyst Briefing in New York City. Among the data [...]
September 23, 2008
SAN DIEGO, Calif.--September 23, 2008 -- eBioscience Corporation, a leading global provider of innovative high quality cell analysis reagents, announced today the expansion of its multicolor cellular analysis portfolio with the introduction of its eFluorTM brand and the commercial launch of the eFluorTM Nanocrystals product line. "The development of innovative, high value multicolor cellular analysis [...]
e2v to Establish Next Generation Biosensor System Using AbD Serotec-generated HuCAL Antibodies
September 23, 2008
e2v biosensors, a subsidiary of e2v technologies plc, and AbD Serotec, the division for research and diagnostic antibodies of MorphoSys AG, today launched a research programme to establish e2v’s proprietary biosensor system Visucare™, a novel detection technology for biomarkers using a single-antibody immunoassay. The Visucare™ system will be used for protein quantification in point of [...]
